Trials / Sponsors / GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumo Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma | Phase 1 | 2019-08-13 |